Faehling, M., Volckmar, A., & Stenzinger, A. (2017). Oncogenic driver mutations, treatment, and EGFR-TKI resistance in a Caucasian population with non-small cell lung cancer: Survival in clinical practice. OncoTarget, 8(44), . https://doi.org/10.18632/oncotarget.20857
Chicago-Zitierstil (17. Ausg.)Faehling, Martin, Anna-Lena Volckmar, und Albrecht Stenzinger. "Oncogenic Driver Mutations, Treatment, and EGFR-TKI Resistance in a Caucasian Population with Non-small Cell Lung Cancer: Survival in Clinical Practice." OncoTarget 8, no. 44 (2017). https://doi.org/10.18632/oncotarget.20857.
MLA-Zitierstil (9. Ausg.)Faehling, Martin, et al. "Oncogenic Driver Mutations, Treatment, and EGFR-TKI Resistance in a Caucasian Population with Non-small Cell Lung Cancer: Survival in Clinical Practice." OncoTarget, vol. 8, no. 44, 2017, https://doi.org/10.18632/oncotarget.20857.